Nanotubes from bacteriophage tail sheath proteins: internalisation by cancer cells and macrophages DOI Creative Commons
Dovydas Gabrielaitis, Vilmantė Žitkutė,

Lina Saveikyte

et al.

Nanoscale Advances, Journal Year: 2023, Volume and Issue: 5(14), P. 3705 - 3716

Published: Jan. 1, 2023

Bionanoparticles comprised of naturally occurring monomers are gaining interest in the development novel drug transportation systems. Here we report on stabilisation, cellular uptake, and macrophage clearance nanotubes formed from self-assembling gp053 tail sheath protein vB_EcoM_FV3 bacteriophage. To evaluate potential bacteriophage protein-based as therapeutic nanocarriers, investigated their internalisation into colorectal cancer cell lines professional macrophages that may hinder applications by clearing nanotube carriers. We fused with a SNAP-tag self-labelling enzyme demonstrated its activity is retained assembled nanotubes, indicating such carriers can be applied to deliver biomolecules. Under physiological conditions, stabilisation PEGylation was required prevent aggregation yield stable solution uniform nano-sized structures. Colorectal carcinoma cells primary metastatic tumours internalized SNAP-tag-carrying different efficiencies. The entered HCT116 via dynamin-dependent SW480 - dynamin- clathrin-dependent pathways were accumulated lysosomes. Meanwhile, peritoneal phagocytosed highly efficient manner through actin-dependent mechanisms. Macrophage enhanced inflammatory activation but dampened isolated aged animals. Altogether, our results demonstrate cargo's enzymatic post-assembly had capacity enter cells. Furthermore, emphasise importance evaluating nanocarrier immune under conditions mimicking cancerous environment.

Language: Английский

Biological landscape and nanostructural view in development and reversal of oxaliplatin resistance in colorectal cancer DOI Creative Commons
Mehrdad Hashemi, Nastaran Esbati, Mohsen Rashidi

et al.

Translational Oncology, Journal Year: 2023, Volume and Issue: 40, P. 101846 - 101846

Published: Dec. 1, 2023

The treatment of cancer patients has been mainly followed using chemotherapy and it is a gold standard in improving prognosis survival rate patients. Oxaliplatin (OXA) third-platinum anti-cancer agent that reduces DNA synthesis cells to interfere with their growth cell cycle progression. In spite promising results OXA chemotherapy, the process drug resistance made some challenges. commonly applied colorectal (CRC) as malignancy gastrointestinal tract when CRC increase proliferation metastasis, they can obtain chemotherapy. A number molecular factors such CHK2, SIRT1, c-Myc, LATS2 FOXC1 have considered regulators response cells. non-coding RNAs are able function master regulator other pathways modulating resistance. There close association between mechanisms apoptosis, autophagy, glycolysis EMT resistance, so apoptosis inhibition, pro-survival autophagy induction stimulation induce anti-tumor compounds including astragaloside IV, resveratrol nobiletin enhance sensitivity Nanoparticles for increasing potential suppression reversing employed These subjects covered this review article shed light on resulting

Language: Английский

Citations

7

Multichannel-optical imaging for in vivo evaluating the safety and therapeutic efficacy of stem cells in tumor model in terms of cell tropism, proliferation and NF-κB activity DOI

Dehua Huang,

Xue Yang, Zhao Peng

et al.

Biomaterials, Journal Year: 2024, Volume and Issue: 307, P. 122510 - 122510

Published: Feb. 23, 2024

Language: Английский

Citations

2

Biomimetic modification of macrophage membrane-coated prussian blue nanoparticles loaded with SN-38 to treat colorectal cancer by photothermal-chemotherapy DOI

Xuyang Hou,

Zuxing Wei,

Xiaoyan Qi

et al.

Drug Delivery and Translational Research, Journal Year: 2024, Volume and Issue: unknown

Published: Sept. 9, 2024

Language: Английский

Citations

1

Anti-EpCAM Functionalized I-131 Radiolabeled Biomimetic Nanocarrier Sodium/Iodide-Symporter-Mediated Breast-Cancer Treatment DOI Creative Commons
Suphalak Khamruang Marshall,

Yada Panrak,

Naritsara Makchuchit

et al.

Bioengineering, Journal Year: 2022, Volume and Issue: 9(7), P. 294 - 294

Published: June 30, 2022

Currently, breast-cancer treatment has a number of adverse side effects and is associated with poor rates progression-free survival. Therefore, radiolabeled anti-EpCAM targeted biomimetic coated nanocarrier (EINP) was developed in this study to overcome some the challenges. The double emulsion method synthesized poly(lactic-co-glycolic acid) (PLGA) nanoparticle Na131I entrapped core. PLGA human red blood cell membranes labeled epithelial adhesion molecule (EpCAM) antibody enable it target EpCAM overexpression by cells. Characterization determined EINP size as 295 nm, zeta potential −35.9 mV, polydispersity 0.297. radiochemical purity >95%. Results efficacy against positive MCF-7 breast cancer at 24, 48, 72 h were 69.11%, 77.84%, 74.6%, respectively, demonstrating that EINPs achieved greater cytotoxic supported NIS-mediated uptake than non-targeted 131INPs Na131I. In comparison, fibroblast (EpCAM negative) treated had significantly lower cytotoxicity (p < 0.05). Flow cytometry fluorescence imaging visually signified delivery specifically cells result targeting. Additionally, favorable safety profile, hemolysis.

Language: Английский

Citations

6

Nanotubes from bacteriophage tail sheath proteins: internalisation by cancer cells and macrophages DOI Creative Commons
Dovydas Gabrielaitis, Vilmantė Žitkutė,

Lina Saveikyte

et al.

Nanoscale Advances, Journal Year: 2023, Volume and Issue: 5(14), P. 3705 - 3716

Published: Jan. 1, 2023

Bionanoparticles comprised of naturally occurring monomers are gaining interest in the development novel drug transportation systems. Here we report on stabilisation, cellular uptake, and macrophage clearance nanotubes formed from self-assembling gp053 tail sheath protein vB_EcoM_FV3 bacteriophage. To evaluate potential bacteriophage protein-based as therapeutic nanocarriers, investigated their internalisation into colorectal cancer cell lines professional macrophages that may hinder applications by clearing nanotube carriers. We fused with a SNAP-tag self-labelling enzyme demonstrated its activity is retained assembled nanotubes, indicating such carriers can be applied to deliver biomolecules. Under physiological conditions, stabilisation PEGylation was required prevent aggregation yield stable solution uniform nano-sized structures. Colorectal carcinoma cells primary metastatic tumours internalized SNAP-tag-carrying different efficiencies. The entered HCT116 via dynamin-dependent SW480 - dynamin- clathrin-dependent pathways were accumulated lysosomes. Meanwhile, peritoneal phagocytosed highly efficient manner through actin-dependent mechanisms. Macrophage enhanced inflammatory activation but dampened isolated aged animals. Altogether, our results demonstrate cargo's enzymatic post-assembly had capacity enter cells. Furthermore, emphasise importance evaluating nanocarrier immune under conditions mimicking cancerous environment.

Language: Английский

Citations

3